Association between chronic atrophic gastritis and serum antibodies to 15 Helicobacter pylori proteins measured by multiplex serology.

Infection with Helicobacter pylori is a major risk factor for chronic atrophic gastritis (CAG), a precursor lesion of intestinal gastric cancer. The pathogenicity of the bacterium is thought to play an important role in determining the extent and severity of clinical outcome. We aimed to assess the associations between CAG and the serostatus of antibodies to 15 H. pylori proteins. The analyses were based on 534 cases with serologically defined CAG and 1,068 age-matched and sex-matched controls participating in a population-based study conducted in Saarland, Germany among 9,953 men and women ages 50 to 74 years. A newly developed H. pylori multiplex serology method was used to detect antibodies specific to 15 H. pylori antigens. Significant associations were observed between seropositivity for all 15 specific antibodies and the presence of CAG. Exclusion of severe cases, who might have lost the infection in the course of CAG progression, substantially increased the observed associations. In H. pylori-seropositive subjects, cytotoxin-associated gene A (CagA), vacuolating toxin (VacA), helicobacter cysteine-rich protein C (HcpC), and the chaperonin GroEL were identified as independent virulence factors for CAG with adjusted odds ratios (95% confidence interval) of 3.52 (2.01-6.10), 3.19 (1.44-7.05), 4.03 (1.53-10.65), and 2.65 (1.06-6.62), respectively; the simultaneous presence of all four independent virulence factors was associated with an 18-fold risk of CAG. In conclusion, HcpC and GroEL were identified as new independent virulence factors, and in combination with the established virulence factors, CagA and VacA, were strongly associated with CAG.

[1]  M. Vieth,et al.  Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: The Kalixanda study , 2008, Scandinavian journal of gastroenterology.

[2]  H. Brenner,et al.  Epidemiologic findings on serologically defined chronic atrophic gastritis strongly depend on the choice of the cutoff‐value , 2007, International journal of cancer.

[3]  P. Correa,et al.  Carcinogenesis of Helicobacter pylori. , 2007, Gastroenterology.

[4]  A. Svennerholm,et al.  Oral immunization with HpaA affords therapeutic protective immunity against H. pylori that is reflected by specific mucosal immune responses. , 2007, Vaccine.

[5]  F. Clavel-Chapelon,et al.  CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC‐EURGAST study , 2007, International journal of cancer.

[6]  M. Chung,et al.  Quantitative Analysis of Representative Proteome Components and Clustering of Helicobacter pylori Clinical Strains , 2006, Helicobacter.

[7]  Y. Goto,et al.  Genetic factors involved in the development of Helicobacter pylori‐related gastric cancer , 2006, Cancer science.

[8]  D. Kang,et al.  CagA-producing Helicobacter pylori and increased risk of gastric cancer: a nested case–control study in Korea , 2006, British Journal of Cancer.

[9]  Ding-Shinn Chen,et al.  Comparative Immunoproteomics of Identification and Characterization of Virulence Factors from Helicobacter pylori Related to Gastric Cancer * S , 2006, Molecular & Cellular Proteomics.

[10]  H. Brenner,et al.  Prevalence of Chronic Atrophic Gastritis in Different Parts of the World , 2006, Cancer Epidemiology Biomarkers & Prevention.

[11]  A. Scaloni,et al.  Comparative proteomics and immunoproteomics of Helicobacter pylori related to different gastric pathologies. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[12]  G. Bergonzelli,et al.  GroEL of Lactobacillus johnsonii La1 (NCC 533) Is Cell Surface Associated: Potential Role in Interactions with the Host and the Gastric Pathogen Helicobacter pylori , 2006, Infection and Immunity.

[13]  D. Forman,et al.  Gastric cancer: global pattern of the disease and an overview of environmental risk factors. , 2006, Best practice & research. Clinical gastroenterology.

[14]  D. Graham,et al.  Helicobacter pylori virulence factors: facts and fantasies , 2005, Current opinion in gastroenterology.

[15]  Markus F Templin,et al.  Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. , 2005, Clinical chemistry.

[16]  P. Mittl,et al.  Characterization of the Helicobacter pylori Cysteine-Rich Protein A as a T-Helper Cell Type 1 Polarizing Agent , 2005, Infection and Immunity.

[17]  V. Govorun,et al.  Comparative Analysis of Transcription Profiles of Helicobacter pylori Clinical Isolates , 2005, Biochemistry (Moscow).

[18]  T. Meyer,et al.  Identification of candidate antigens for serologic detection of Helicobacter pylori‐infected patients with gastric carcinoma , 2004, International journal of cancer.

[19]  S. Dhar,et al.  Molecular mechanism of action of major Helicobacter pylori virulence factors , 2003, Molecular and Cellular Biochemistry.

[20]  I. Zuna,et al.  Serum Antibodies Against Helicobacter pylori Proteins VacA and CagA Are Associated with Increased Risk for Gastric Adenocarcinoma , 1997, Digestive Diseases and Sciences.

[21]  R. Hunt,et al.  Meta-analysis of the relationship between cagA seropositivity and gastric cancer. , 2003, Gastroenterology.

[22]  P. Mittl,et al.  Detection of High Titers of Antibody against Helicobacter Cysteine-Rich Proteins A, B, C, and E in Helicobacter pylori-Infected Individuals , 2003, Clinical Diagnostic Laboratory Immunology.

[23]  J. Virtamo,et al.  Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis , 2003, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[24]  R. Haas,et al.  Identification and Characterization of Helicobacter pylori Genes Essential for Gastric Colonization , 2003, The Journal of experimental medicine.

[25]  S. Hazell,et al.  Catalase (KatA) and KatA-associated protein (KapA) are essential to persistent colonization in the Helicobacter pylori SS1 mouse model. , 2003, Microbiology.

[26]  Nayoung Kim,et al.  Proteins Released by Helicobacter pylori In Vitro , 2002, Journal of bacteriology.

[27]  T. Meyer,et al.  Multiparameter Selection of Helicobacter pylori Antigens Identifies Two Novel Antigens with High Protective Efficacy , 2002, Infection and Immunity.

[28]  Risk factors for atrophic chronic gastritis in a European population: results of the Eurohepygast study , 2002, Gut.

[29]  Toni Aebischer,et al.  Immunoproteomics of Helicobacter pylori infection and relation to gastric disease , 2002, Proteomics.

[30]  J. d'Alayer,et al.  Novel Antigens of Helicobacter pylori Correspond to Ulcer-Related Antibody Pattern of Sera from Infected Patients , 2002, Journal of Clinical Microbiology.

[31]  M. Blaser,et al.  Helicobacter pylori and gastrointestinal tract adenocarcinomas , 2002, Nature Reviews Cancer.

[32]  R. Haas,et al.  Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin‐8 , 2003, Molecular microbiology.

[33]  R. Haas,et al.  Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin‐8 , 2001 .

[34]  Y. Shiratori,et al.  Virulence Factors of Helicobacter pylori Responsible for Gastric Diseases in Mongolian Gerbil , 2000, The Journal of experimental medicine.

[35]  R. Rappuoli,et al.  The Neutrophil-Activating Protein (Hp-Nap) of Helicobacter pylori Is a Protective Antigen and a Major Virulence Factor , 2000, The Journal of experimental medicine.

[36]  W. Goebel,et al.  Identification of Immunodominant Antigens fromHelicobacter pylori and Evaluation of Their Reactivities with Sera from Patients with Different Gastroduodenal Pathologies , 2000, Infection and Immunity.

[37]  A. Munakata,et al.  VacA seropositivity is not associated with the development of gastric cancer in a Japanese population. , 1999, European journal of gastroenterology & hepatology.

[38]  R. Rappuoli,et al.  Helicobacter pylori virulence and genetic geography. , 1999, Science.

[39]  E. J. Kuipers,et al.  Review article: exploring the link between Helicobacter pylori and gastric cancer , 1999, Alimentary pharmacology & therapeutics.

[40]  G. Perez-Perez,et al.  Infection with CagA+ Helicobacter pylori strains as a possible predictor of risk in the development of gastric adenocarcinoma in Mexico , 1998, International journal of cancer.

[41]  T. Monath,et al.  Rectal and Intranasal Immunizations with Recombinant Urease Induce Distinct Local and Serum Immune Responses in Mice and Protect against Helicobacter pyloriInfection , 1998, Infection and Immunity.

[42]  T. Fujioka,et al.  Biopsy Sites Suitable for the Diagnosis of Helicobacter pylori Infection and the Assessment of the Extent of Atrophic Gastritis , 1998, American Journal of Gastroenterology.

[43]  I. Corthésy-Theulaz,et al.  Mice Are Protected from Helicobacter pylori Infection by Nasal Immunization with AttenuatedSalmonella typhimurium phoPc Expressing Urease A and B Subunits , 1998, Infection and Immunity.

[44]  M. Blaser,et al.  Pathogenesis of the transformation from gastritis to malignancy , 1998, Alimentary pharmacology & therapeutics.

[45]  H. Mobley,et al.  Defining Helicobacter pylori as a pathogen: strain heterogeneity and virulence. , 1996, The American journal of medicine.

[46]  I. Kansau,et al.  Heat shock proteins of Helicobacter pylori. , 1996, Alimentary pharmacology & therapeutics.

[47]  K. Chapman An international perspective on anticholinergic therapy. , 1996, The American journal of medicine.

[48]  E. Kuipers,et al.  Helicobacter pylori and atrophic gastritis: importance of the cagA status. , 1996, Journal of the National Cancer Institute.

[49]  M. Dixon,et al.  Observer variation in the assessment of chronic gastritis according to the Sydney system , 1994, Histopathology.

[50]  W. Karnes,et al.  Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. , 1991, Gastroenterology.

[51]  M. Blaser Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. , 1990, The Journal of infectious diseases.

[52]  S. Tannenbaum,et al.  A MODEL FOR GASTRIC CANCER EPIDEMIOLOGY , 1975, The Lancet.